SB-773812 Uses, Dosage, Side Effects and more
SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).
Trade Name | SB-773812 |
Generic | SB-773812 |
Type | |
Formula | C25H26ClNO4S |
Weight | Average: 472.0 Monoisotopic: 471.1271072 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |